Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Stallergenes Greer Makes Senior Appointment

This article was originally published in Scrip

Executive Summary

Stallergenes Greer Plc., a company specialising in allergy immunotherapy, has appointed Michele Antonelli executive vice president, head of international operations. Prior to Stallergenes Greer, Antonelli held various positions at UCB, with the most recent being executive vice president and head of immunology Europe. Before UCB, Antonelli spent 16 years at Merck Serono, ultimately in the role of senior vice president and global head of biotech manufacturing and process development in Geneva.

Advertisement

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register